Both TMX and TFP induce apoptosis in cholangiocarcinoma (Pawar et al., 2009), and it is interesting that the CaM interactor BASP1 was reported to enhance the antitumorigenic effect of TMX in breast cancer (Marsh et al., 2017). The gene discussed is CALM1; the disease is cholangiocarcinoma.